Your browser doesn't support javascript.
loading
Bcl-xL is an oncogenic driver in colorectal cancer.
Scherr, Anna-Lena; Gdynia, Georg; Salou, Mariam; Radhakrishnan, Praveen; Duglova, Katarina; Heller, Anette; Keim, Sophia; Kautz, Nicole; Jassowicz, Adam; Elssner, Christin; He, You-Wen; Jaeger, Dirk; Heikenwalder, Mathias; Schneider, Martin; Weber, Achim; Roth, Wilfried; Schulze-Bergkamen, Henning; Koehler, Bruno Christian.
Afiliação
  • Scherr AL; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • Gdynia G; Clinical Cooperation Unit (CCU) Molecular Tumor Pathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Salou M; Institute of Pathology, Department of Surgical Pathology, University Hospital Heidelberg, Heidelberg 69120, Germany.
  • Radhakrishnan P; Division of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Duglova K; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg 69120, Germany.
  • Heller A; Institute of Pathology, Department of Surgical Pathology, University Hospital Heidelberg, Heidelberg 69120, Germany.
  • Keim S; Institute of Pathology, Department of Surgical Pathology, University Hospital Heidelberg, Heidelberg 69120, Germany.
  • Kautz N; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • Jassowicz A; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • Elssner C; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • He YW; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • Jaeger D; Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.
  • Heikenwalder M; National Center for Tumor Diseases, Department of Medical Oncology and Heidelberg University Hospital, Internal Medicine VI, 69120 Heidelberg, Germany.
  • Schneider M; Institute of Virology, Technische Universität München and Helmholtz Zentrum München, Munich 81675, Germany.
  • Weber A; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Roth W; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg 69120, Germany.
  • Schulze-Bergkamen H; Institute of Surgical Pathology, University and University Hospital Zurich, Zurich 8091, Switzerland.
  • Koehler BC; Institute of Pathology, University Medical Center Mainz, Mainz 55131, Germany.
Cell Death Dis ; 7(8): e2342, 2016 08 18.
Article em En | MEDLINE | ID: mdl-27537525
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Neoplasias Colorretais / Proteína bcl-X Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncogenes / Neoplasias Colorretais / Proteína bcl-X Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article